The Effect of Tetanus-Diphtheria-Acellular-Pertussis Immunization During Pregnancy on Infant Antibody Responses: Individual-Participant Data Meta-Analysis
Related Experiment Video
Updated: Oct 26, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Bahaa Abu-Raya1,2, Kirsten Maertens3, Flor M Munoz4
1Vaccine Evaluation Center, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada.
Insights
Maternal tetanus-diphtheria-acellular pertussis (Tdap) vaccination in pregnancy leads to lower infant antibody responses to pertussis and diphtheria. Enhanced surveillance for these diseases in infants is recommended.
Area of Science:
- Immunology
- Vaccinology
- Maternal and Child Health
Background:
- Maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine during pregnancy is increasingly recommended.
- The impact of maternal Tdap vaccination on infant immune responses to routine childhood immunizations requires thorough investigation.
Purpose of the Study:
- To determine the effect of maternal Tdap immunization during pregnancy on infants' antibody responses to routine vaccines.
- To compare antibody levels and seroprotection rates in infants born to Tdap-immunized mothers versus unimmunized mothers.
Main Methods:
- An individual-participant data meta-analysis was conducted, pooling data from ten studies with 1884 participants.
- Infants' antigen-specific immunoglobulin G (IgG) levels and seroprotection rates were analyzed using mixed-effects models and chi-squared tests.
Main Results:
- Infants of Tdap-immunized mothers showed significantly lower IgG levels against pertussis components (pertussis toxin, FHA, pertactin, FIM2/3) and diphtheria after primary immunization.
- Lower antibody levels persisted for some pertussis antigens after booster immunization.
- Infants of Tdap-immunized mothers had lower seroprotection rates against diphtheria and certain *Streptococcus pneumoniae* (SPN) serotypes, but higher rates against *Haemophilus influenzae* type b.
Conclusions:
- Maternal Tdap vaccination in pregnancy is associated with reduced infant antibody responses to pertussis, diphtheria, and some SPN serotypes.
- Clinical significance necessitates enhanced surveillance of pertussis, diphtheria, and invasive pneumococcal disease (IPD) in infants born to vaccinated mothers.
Background:
Immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in pregnancy is increasingly recommended. We determined the effect of Tdap immunization in pregnancy on infants' vaccine responses.
Methods:
Individual-participant data meta-analysis of ten studies (n=1884) investigating infants' antibody response to routine immunizations following Tdap immunization in pregnancy was performed. Geometric mean ratios (GMRs) of antigen-specific immunoglobulin G (IgG) levels were calculated using mixed-effects models. Seroprotection rates were compared using chi-squared tests.
Results:
Infants of Tdap-immunized women had significantly lower IgG against pertussis toxin (GMR 0.65; 95%CI 0.57-0.74), filamentous haemagglutinin (FHA) (0.68; 0.53-0.87), pertactin (0.65; 0.58-0.72) and fimbria 2/3 (FIM2/3) (0.41; 0.32-0.52) after primary immunization, compared with infants of unimmunized women. These lower levels persisted after booster immunization for FHA (0.72; 0.61-0.84) and FIM2/3 (0.53; 0.29-0.96). After primary immunization, infants of Tdap-immunized women had lower seroprotection rates against diphtheria (90% [843/973] vs 98% [566/579]; p<0.001) and invasive pneumococcal disease (IPD) caused by 5 Streptococcus pneumoniae (SPN) serotypes (SPN5, SPN6B, SPN9V, SPN19A, SPN23F), and higher seroprotection rates against Haemophilus influenzae type b (short-term and long-term seroprotection rates, 86%[471/547] vs 76%[188/247] and 62%[337/547] vs 49%(121/247), respectively, all p=0.001). After booster immunization, seroprotection rates against diphtheria and tetanus were 99% (286/288) and (618/619) in infants of Tdap-immunized women, respectively.
Conclusions:
Infants of Tdap-immunized women in pregnancy had lower IgG levels against pertussis, diphtheria and some SPN serotypes after their immunization compared with infants of unimmunized women. Enhanced surveillance of pertussis, diphtheria and IPD in infants is needed to determine the clinical significance of these findings.
Systematic Review Registration:
CRD42017079171.
More Related Videos
09:09Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
Related Concept Videos
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Vaccinations
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Teratogenicity